Join
Live feed
·
PRReleasevia Quantisnow
Trevi Therapeutics Inc. logo

Trevi Therapeutics Announces Positive Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough

ByQuantisnow·Wall Street's wire, on your screen.
TRVI· Trevi Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRVI (Trevi Therapeutics Inc.) and more on Quantisnow.